Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Banner

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Clinical and Experimental Immunology|December 9, 1998
Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapyT F Logan, B Banner, U Rao, et al.
Annals of Surgery|October 1, 1987
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator responseL Makowka, C Miller, P Chapchap, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 1, 1989
A modified technique of orthotopic transplant of the kidney in rabbitsV Mazzaferro, L Makowka, F Enrichens, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Mucosal recipient-type mononuclear repopulation and low-grade chronic rejection occur simultaneously in indefinitely surviving recipients of small bowel allograftsJ M Langrehr, A J Demetris, B Banner, et al.
Medicine|January 1, 1994
Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literatureJ M Levey, B Bjornsson, B Banner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinomaM S Ernstoff, S Nair, R R Bahnson, et al.
Cancer Research|February 15, 1992
Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trialM S Ernstoff, W Gooding, S Nair, et al.
Hepatology (Baltimore, Md.)|June 28, 2000
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trialA M Di Bisceglie, H L Bonkovsky, S Chopra, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Clinical and Experimental Immunology|December 9, 1998
Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapyT F Logan, B Banner, U Rao, et al.
Annals of Surgery|October 1, 1987
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator responseL Makowka, C Miller, P Chapchap, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 1, 1989
A modified technique of orthotopic transplant of the kidney in rabbitsV Mazzaferro, L Makowka, F Enrichens, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Mucosal recipient-type mononuclear repopulation and low-grade chronic rejection occur simultaneously in indefinitely surviving recipients of small bowel allograftsJ M Langrehr, A J Demetris, B Banner, et al.
Medicine|January 1, 1994
Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literatureJ M Levey, B Bjornsson, B Banner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinomaM S Ernstoff, S Nair, R R Bahnson, et al.
Cancer Research|February 15, 1992
Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trialM S Ernstoff, W Gooding, S Nair, et al.
Hepatology (Baltimore, Md.)|June 28, 2000
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trialA M Di Bisceglie, H L Bonkovsky, S Chopra, et al.
Pageof 6